Among other variants, we could find a CD44 P16S missense variant, with a VAF of 5.5%, which was previously reported in relapsed/refractory DLBCL [25], but not in IVLBCL case series by Shimada and collaborators, who found a CD44 mutation in a different codon [9]. Here, CD44 is linked to diffuse large B-cell lymphoma.